Anchor Investors Help Anthem Biosciences Raise Rs 1,016 Crore – GNP News

Anthem Biosciences Secures Rs 1,016 Crore Funding

Anthem Biosciences has successfully secured Rs 1,016 crore from anchor investors, marking a significant milestone for the company. This funding comes just before the company’s upcoming initial public offering (IPO) that will be open to public subscription.

Investors and Participation

Key investors who participated in the anchor book include prestigious names such as Abu Dhabi Investment Authority, Government Pension Fund Global, Eastspring Investments, Amundi Funds, PineBridge Global Funds, and Societe Generale. Additionally, notable mutual funds like HDFC MF, ICICI Prudential MF, Axis MF, UTI MF, Quant MF, and Motilal Oswal MF also took part in the investment round.

Equity Shares Allocation

According to reports, Anthem Biosciences has allocated 1.78 crore equity shares to 60 funds at a price of Rs 570 per share, which is at the upper end of the price band. This move has resulted in the total transaction size amounting to Rs 1,016 crore, showcasing strong investor interest in the company.

Upcoming IPO Details

The IPO of the Bengaluru-based firm is set to open for public subscription on July 14 and will conclude on July 16. The price band for the shares has been established at Rs 540-570 per share, offering investors the opportunity to partake in the company’s growth journey.

Offer-for-Sale Model

It is important to note that the IPO is structured as an offer-for-sale, where the company will not receive any proceeds from the issuance of shares. Instead, the funds raised will go directly to the selling shareholders, reflecting the company’s commitment to shareholder value.

With this successful fundraising and the upcoming IPO, Anthem Biosciences is poised for an exciting chapter ahead, driven by investor confidence and strong market support.

References: BSE India, The Economic Times


📌 Also Read:

Global News Plus (GNP):